Growth Metrics

STRATA Skin Sciences (SSKN) Gains from Investment Securities (2016 - 2025)

STRATA Skin Sciences' Gains from Investment Securities history spans 13 years, with the latest figure at $83000.0 for Q4 2025.

  • On a quarterly basis, Gains from Investment Securities rose 854.55% to $83000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $59000.0, a 3050.0% increase, with the full-year FY2025 number at $34000.0, down 93.48% from a year prior.
  • Gains from Investment Securities hit $83000.0 in Q4 2025 for STRATA Skin Sciences, up from $16576.0 in the prior quarter.
  • Over the last five years, Gains from Investment Securities for SSKN hit a ceiling of $7.3 million in Q3 2024 and a floor of -$17000.0 in Q1 2022.
  • Historically, Gains from Investment Securities has averaged $2.6 million across 5 years, with a median of $83000.0 in 2025.
  • Biggest five-year swings in Gains from Investment Securities: surged 19075.5% in 2023 and later plummeted 150.0% in 2024.
  • Tracing SSKN's Gains from Investment Securities over 5 years: stood at $73000.0 in 2021, then soared by 6125.64% to $4.5 million in 2022, then crashed by 99.52% to $22000.0 in 2023, then plummeted by 150.0% to -$11000.0 in 2024, then surged by 854.55% to $83000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SSKN at $83000.0 in Q4 2025, $16576.0 in Q3 2025, and -$11000.0 in Q4 2024.